ISRCTN39282347进行中(未招募)未知
Short-term specialized palliative care intervention in primary care for frail older people and their family carers
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 入组人数
- 37
研究概览
简要总结
2021 protocol in https://pubmed.ncbi.nlm.nih.gov/33472789/ (added 22/01/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 70 years or over
- •2. Clinical Frailty Scale (CFS) score > 5 (mild to severe)
- •3. One or more unresolved or complex* symptoms or problems (as judged by clinicians)
- •4. In a hospital and referred to return to their home in the region Gent-Eeklo or Dendermonde-Aalst-Ninove
- •5. Speak and understand Dutch, and provide informed consent to participate in the study OR when a person lacks capacity to consent for themselves the procedures detailed in the Belgian law for patient rights are adhered to
- •6. Have a family carer who is eligible and willing to participate (see below for inclusion criteria for family carers) OR does not have a family member corresponding to the inclusion criteria
- •*one or more unresolved or complex symptoms or problems can include a multitude of different situations such as:
- •3.1 Complex patients’ needs on the physical, psychological, social and/or spiritual domain
- •3.2 Complex end-of-life issues such as being ‘tired of living’, highly conflicted decision-making, consideration of palliative sedation, requests for assisted dying or euthanasia
- •3.3 Difficulties with advance care planning
- •3.4 Complex patient characteristics such as multimorbidity, or complexity due to cumulation of problems
- •3.5 Cre-existing complexity, for example, long-standing difficulties with finances/housing, mental health needs
- •3.6 Difficult interactions between the patient, family and healthcare professionals (for example, dissonance or conflicts, older patients who do not seek help etc)
- •7. To pilot the trial and evaluate the intervention specifically in the population of frail older people with cancer, we will oversample people with a cancer diagnosis into the study sample. To do so, we will apply the following inclusion critierion, in addition to the ones specified above:
- •7.1 Advanced-stage solid tumor or hematologic malignancy
- •8. Inclusion criteria for family carers:
- •8.1 Patient (or health care provider if patient does not have capacity) indicated that they are the patients’ main family carer or representative
- •8.2 This person lives with the patient or has in-person contact with him or her at least twice a week
排除标准
- •1. One or more palliative care consultations (i.e. specialized palliative home care team and/or palliative care unit) in the 6 months prior to inclusion in the study
- •2. Taken/are taking part in another research study that is evaluating palliative care services
- •3. Urgent palliative care needs (and should be referred to specialized palliative care) and/or deteriorate rapidly
- •4. Do not speak and/or understand Dutch
- •5. Exclusion criteria for family carers:
- •5.1 Have taken/are taking part in another research study that is evaluating palliative care services
- •5.2 Do not speak and/or understand Dutch
研究者
相似试验
进行中(未招募)
不适用
A multi-site trial of specialist palliative care in cystic fibrosisCystic fibrosis in adultsNutritional, Metabolic, EndocrineCystic fibrosisISRCTN53323164Emory University264
进行中(未招募)
不适用
Gardens for people with dementiaISRCTN14095773The Velux Foundations138
已完成
不适用
Improving end of life in care homes using an implementation science approachHealth services research, care homes, end of life careISRCTN15863801niversity of Stirling349
已完成
不适用
A single site, open label, phase I study to assess the safety and feasibility of foetal cell transplants in the striatum of people with Huntington’s diseaseHuntington's diseaseNervous System DiseasesHuntington diseaseISRCTN52651778Cardiff University22
已完成
不适用
A resource for advance care planning in multiple sclerosisPeople with severe progressive multiple sclerosis (pwPMS) across various health care settings in ItalyNervous System DiseasesMultiple sclerosisISRCTN48527663Istituto Neurologico Carlo Besta38
